Excitement over new urine test for prostate cancer
Test predicts disease progression up to five years before standard clinical methods: authors
UK researchers say they have developed a urine test that can detect whether a prostate cancer tumour is aggressive or whether the patient can be put on surveillance.
They have developed the prostate urine risk test by looking for genetic markers in urine samples from 535 men.
Researchers generated four signatures for predicting the probability of normal tissue, D’Amico low‐risk, intermediate-risk and high-risk prostate cancer.
This model was applied to a test cohort of 177 patients for diagnostic evaluation and to an active surveillance subgroup of 87 men for prognostic assessment.
